Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 10
Submit an article Journal homepage
170
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment disparities in minority groups with multiple myeloma at a safety-net hospital

Michael DennisDepartment of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USA;
,
Asaf MaozDepartment of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USA;
,
Diana CirsteaSection of Hematology & Medical Oncology, Department of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USA
,
Ami PatelSection of Hematology & Medical Oncology, Department of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USA
,
Adam LernerSection of Hematology & Medical Oncology, Department of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USA
&
Shayna SarosiekSection of Hematology & Medical Oncology, Department of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, MA, USACorrespondence[email protected]
Pages 2507-2510 | Received 15 Sep 2019, Accepted 30 Apr 2020, Published online: 27 May 2020

References

  • Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116(25):5501–5506.
  • Ailawadhi S, Aldoss IT, Yang D, et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br J Haematol. 2012;158(1):91–98.
  • Baker A, Braggio E, Jacobus S, et al. Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach. Blood. 2013;121(16):3147–3152.
  • Costa LJ, Brill IK, Brown EE. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States. Cancer. 2016;122(20):3183–3190.
  • Ailawadhi S, Frank RD, Sharma M, et al. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities. Cancer. 2018;124(8):1710–1721.
  • Cavo M, Pantani L, Pezzi A, et al. Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma. Leukemia. 2015;29(12):2429–2431.
  • Durie B, Hoering A, Abidi M, et al. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial. Lancet. 2017;389(10068):519–527.
  • Mateos M, Ocio E, Paiva B, et al. Treatment for patients with newly diagnosed multiple myeloma in 2015. Blood Rev. 2015;29(6):387–403.
  • Costa LJ, Huang JX, Hari PN. Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma. Biol Blood Marrow Transplant [Internet]. 2015;21(4):701–706.
  • Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123(9):1590–1596.
  • Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: Exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood Cancer J. 2018;8(7):67.
  • Fillmore NR, Yellapragada SV, Ifeorah C, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019;133(24):2615–2618.
  • Baris D, Brown LM, Silverman DT, et al. Socioeconomic status and multiple myeloma among US Blacks and Whites. Am J Public Health. 2000;90(8):1277–1281.
  • Fiala MA, Finney JD, Liu J, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leuk Lymphoma. 2015;56(9):2643–2649.
  • Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 2019;3(20):2986–2994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.